3.5 AI identification Among the 63 samples, three AI APIs (anastrozole, letrozole, and exemestane) were identified using LC-QTOF-MS/MS (Table 2)
Early amylin analog development was marked by pramlintide's modest clinical impact (~23% weight loss) and poor adherence due to three-times-daily dosing
Lighter individuals may achieve good results at lower doses (300-350mcg)
Similar to semaglutide, cyanocobalamin has relatively few side effects, and those it does have are frequently very minor
*Correspondence: Shuji Kaneko, [email protected] This article was submitted to Translational Pharmacology, a section of the journal Frontiers in Pharmacology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
SERD, selective estrogen receptor degrader